Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Neuroendocrine Tumors 3Acromegaly 2Pituitary Neoplasms 1Neuroendocrine Tumour With Carcinoid Symptoms 1Neoplasms 1Gigantism 1Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

lanreotide 2Octreotide 2Cabergoline 2pegvisomant 1pasireotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Acromegaly × lanreotide × Clear all
NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated
4 enrolled 5 charts
Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

NCT00627796 2008-03-03

ATG1line

Federico II University

Phase 4 Completed
27 enrolled

Acromegaly, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡